Mutations in PPP1R13L cause a novel autosomal-recessive cardio-cutaneous syndrome characterized by fatal infantile dilated cardiomyopathy due to dysregulated cardiac inflammatory responses.
No takes yet. Share an insight, caveat, or question.
May prompt PPP1R13L screening in syndromic infantile DCM; leaves open whether modulating inflammation improves outcomes.
Falik‐Zaccai et al. (2017) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: